Clinical trial
Two-Dose Methotrexate for Ectopic Pregnancy
NCT00194272 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00194272 |
|---|---|
| Title | Two-Dose Methotrexate for Ectopic Pregnancy |
| Official title | Two-Dose Methotrexate for Ectopic Pregnancy |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | Bill and Melinda Gates Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ectopic Pregnancy |
| Intervention type | Drug |
| Interventions | Methotrexate |
| Enrollment | 100 |
| Start date | Mar 1, 2001 |
| Completion | Jun 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Aug 9, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: